Unwavering Support for Healthcare Providers
2026/02/25
2026/03/09
Author: Jian Wang (王健), RAC
Vice President, Quality & Regulatory Affairs at VistaMed Technologies
Jian Wang is a certified Regulatory Affairs professional (RAC) with over 18 years of experience masterfully navigating the complex landscape of international medical device regulations, personally leading VistaMed's successful FDA, CE, and ISO certification efforts.
I recently reviewed a technical file from a potential supplier of non-contact thermometers. Their Instructions For Use (IFU) document was a single page with a cartoon diagram showing a user pointing the device at a forehead. There was no mention of the required measurement distance, the acceptable ambient temperature range, or the cleaning procedure.
I closed the file. The device was a non-starter.
From my perspective as a regulatory affairs professional, "how to use a thermometer correctly" is not a question for a user manual; it is a question for a manufacturer's quality system and technical file. "Correct use" is the result of a validated device being used within its validated parameters. If those parameters are not rigorously defined and tested, the device is a compliance risk, no matter how simple it seems. This FAQ is designed to guide my fellow RA managers through the questions you should be asking to ensure the devices you approve are defensible under audit.
From a VP of Regulatory Affairs
"An auditor doesn't ask if the nurse used the thermometer correctly. They ask if the manufacturer has validated that the device, when used according to the IFU, provides a clinically accurate result. 'Correct use' is a function of a validated design and a robust QMS, not just user training."
– Jian Wang (王健), RAC
For an RA Manager, vetting a potential device partner isn't about the screen brightness. It's about drilling down into the architecture of their quality and compliance systems. These are the questions I ask when a new thermometer comes across my desk.
This is the fundamental question. "Correct use" is a three-part equation: a validated device, used on the correct patient population, in the correct environment, according to a validated IFU.
As RA professionals, we must verify that the manufacturer has objective evidence to support every part of that equation. The core international standard for this is ISO 80601-2-56:2017, which specifies the requirements for the basic safety and essential performance of clinical thermometers. A key part of this standard is the requirement for a clinical investigation to prove the device's accuracy against a reference method. The IFU that the manufacturer provides must reflect the parameters of that investigation. If the device was validated at a distance of 3-5 cm, the IFU must state that. If it was tested on adults, making a claim for neonatal use is a major compliance gap. "Correct use" is simply operating the device within its proven, validated envelope.
You don't. You verify their process for achieving and maintaining that accuracy. A spec sheet is a marketing claim; an audited quality system is evidence.
In my experience preparing 510(k) submissions for the US FDA, I know that reviewers are looking for evidence of a controlled manufacturing process. This means every single thermometer must be calibrated against a certified, NIST-traceable black body radiator in a temperature-controlled environment before it leaves the factory. This process cannot be "batch tested." It must be 100%.
This is where the manufacturer's ISO 13485:2016 Quality Management System certificate is your primary piece of evidence. It proves that a third party, like our auditor BSI (Certificate No. FS 738429), has reviewed and approved their process for calibration, traceability, and quality control. This is also a point of extreme focus for other major regulators. The rigor required for a Class II medical device registration with China's NMPA, for example, involves intense scrutiny of these manufacturing and calibration processes.
The two biggest risks are the sensor and the lens.
These are not just "features." They are critical design choices that determine the device's essential performance. An auditor will see a device with poor optics as having a fundamental design flaw that increases the risk of an inaccurate reading.
This is where a high-quality device pays dividends in reduced compliance workload. Under the European MDR, your PMS plan must be a living system that actively collects real-world data.
A reliable device simply generates fewer reportable events. A device built with cheap components will have a higher failure rate, leading to more complaints that must be investigated and documented. A device with poor thermal stability will generate more readings that are questioned by clinicians, leading to more feedback that must be analyzed.
Consider this: In a project at Unity Health System, standardizing on our monitoring platform led to a 41% decrease in maintenance-related downtime. For an RA manager, that number is gold. It translates to fewer complaint files, fewer CAPAs, and a cleaner PMS report for your Notified Body. A reliable product is a quiet product from a regulatory perspective, and that is an enormous benefit.
Based on my 18 years of navigating these submissions, this is my non-negotiable checklist for vetting a new device vendor. I will not approve a partnership until I have satisfactory answers for every item.
About the Author
Jian Wang (王健), RAC serves as Vice President, Quality & Regulatory Affairs at VistaMed Technologies. As a certified Regulatory Affairs professional (RAC) with over 18 years of experience, he masterfully navigates the complex landscape of international medical device regulations. Jian has personally led the efforts for VistaMed to secure and maintain critical certifications, including FDA 510(k) Clearance, CE Mark under EU MDR 2017/745, and the ISO 13485:2016 quality management system certification (BSI Certificate No. FS 738429). This guide draws on his extensive, first-hand experience in vetting device partners and preparing successful regulatory submissions across the globe.
Clinically & Regulatory Reviewed By: Dr. Michael Bauer, PhD, Head of Clinical Research
The information provided is for informational purposes and intended for a B2B audience of healthcare professionals and procurement decision-makers. It is not a substitute for professional medical or financial advice. TCO and ROI results may vary based on facility size, usage patterns, and local market conditions. All certifications and regulatory clearances referenced are accurate as of the date of publication. Please contact VistaMed Technologies for the most current documentation.